导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -11.35% | 3662/4534 |
| 近一周 | -0.16% | 3608/5179 |
| 近一月 | -1.73% | 893/5111 |
| 近一季 | 0.93% | 1029/4939 |
| 近半年 | -2.98% | 2543/4676 |
| 近一年 | -10.01% | 3286/4214 |
| 近两年 | 19.61% | 2559/2861 |
| 近三年 | 4.14% | 1797/2184 |
| 成立以来 | 19.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-14.93% 4685/4961 |
9.95% 2456/5312 |
- - |
- - |
| 2025 | 5.49% 2996/4813 |
-6.22% 3344/3635 |
4.70% 712/4076 |
8.68% 3401/4524 |
-1.14% 2846/4813 |
| 2024 | 17.42% 691/3463 |
-4.33% 1642/2808 |
-7.07% 2051/3014 |
35.27% 77/3129 |
-2.36% 2057/3463 |
| 2023 | 8.19% 129/2656 |
4.14% 1039/2280 |
-0.60% 392/2385 |
9.11% 10/2515 |
-4.21% 909/2655 |
| 2022 | -23.50% 1139/2207 |
-16.12% 1104/1919 |
-1.17% 1684/2016 |
-12.93% 807/2113 |
5.97% 403/2208 |
| 2021 | -0.88% 766/1822 |
-14.43% 1176/1255 |
8.45% 621/1330 |
6.61% 215/1466 |
0.18% 1161/1822 |
| 2020 | - - |
- - |
- - |
22.21% 37/1164 |
-1.06% 1091/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4796 | 32.41% |
| 港股通药 | 0.9109 | 32.37% |
| 万家中证港股通创新药ETF | 1.6293 | 32.25% |
| 景顺长城中证港股通创新药ETF | 1.6918 | 32.17% |
| 天弘恒生沪深港创新药精选50ETF | 0.8599 | 32.08% |
| 港股医疗 | 0.9703 | 31.90% |
| 港医疗 | 0.9212 | 31.83% |
| 港股通医疗ETF工银 | 0.9798 | 31.81% |
| 港股通医疗ETF华宝 | 0.9918 | 31.64% |
| 万家中证港股通创新药ETF发起式联接A | 1.4193 | 31.06% |
| 汇安上证证券ETF VS. 长安沪深300非周期A(740101) |